The complete peripheral blood count analysis including laboratory screening tests of haemostasis and coagulation should be done in every patient before surgery, in order to detect specific abnormalities for primary or secundary haematologic disorder. These abnormalities might be very important couse of perioperative and postoperative complications. Anaemia is the most frequent haematologic abnormality seen during preoperative period. Therapy approach depends on the type and anaemia degree, and also on the type and time of surgery. If surgery is not urgent specific therapy according to the anaemia type (iron therapy, vitamin B12, folic acid, corticosteroids, recombinant erythropoietin) should be given in all anaemias with deficiency of iron, megaloblastic anaemias, acquired haemolytic anaemias and anaemias in end stage renal disease. Transfusion of red cells are most frequently given in patients with normovolemic anaemias with haemoglobin level of 10,0g/dl and hematocrit of 0,30, but lower levels in haemodynamic stable patients. Venesections should be done in patients with erythrocytosis in order to reduce total red cell volume, but taking into account the perioperative bleeding. Patients with leukocyte abnormalities suspected on primary haematologic disorder need urgent haematologic diagnostic procedures. In patients with leucocytosis the actual level of neutropenia is the bigger problem than the level of leucocytosis. In those patients treatment generally involves preventing infections, managing of febrile neutropenia with broad spectrum antibiotics and antifungal drugs, treatment with recombinant granulocyte hematopoetic factor, rarely transfusions of granulocyte concentrates and intravenous immunoglobulins.
INTRODUCTION
T he complete peripheral blood count analysis including laboratory screening tests of haemostasis and coagulation should be done in every patient before surgery, in order to detect specific abnormalities for primary or secundary haematologic disorder. These abnormalities might be very important cause of perioperative and postoperative complications.
RED BLOOD CELLS DISORDERS
Erythropoiesis is a very complex process, predominantly in bone marrow in adults, regulated by many transcription factors (such as GATA-1 and GATA-2), and growth factors (cytokines).
Erythropoietin, mainly produced in kidney in adults, is the most important growth factor for regulation of erythropoiesis.
Erythropoiesis passes from the stem cell through the common progenitor myeloid (CFU-GEMM) and erytrhoid (BFU-E and CFU-E) cells, meaning many processes including proliferation, differentation and maturation of cells. So, approximately 10 12 new erythrocytes are made each day.The erythocyte mean lifespan is 120 days.
The most important function of red cells is to carry O2 to the tissues, in adequate amaunt and partial tension for O2 diffusion, and to return carbon-dioxide (CO2) from the tissues to the lungs.
It is well known that the red cells are also important for total blood volume regulation (due to their number and high cell deformibility), as well as for the regulation of haemostasis and azote-dioxide realising from the endothel cells.
Those functions might be important for perioperative and postoperative bleeding not caused by the surgery itself. 
Definition of anaemia
Anaemia is the most frequent haematologic abnormality seen during preoperative prepartion of patients.
Anaemia is defined as a reduction in the haemoglobin concentration of the blood.Although normal values can vary between laboratories, typical values for anaemia would be less than 13,5g/dl in adult males and less than 11,5g/dl in adult females. From the age of 2 years to puberty, less than 11,0g/dl indicates anaemia. As newborn infants have a high haemoglobin level, 14,0g/dl is taken as the lower limit at birth. Alterations in total circulating plasma volume may significantly determine haemoglobin level. So, reduction in plasma volume (as in dehidration) may mask anaemia or even cause erythrocytosis; conversely, an increase in plasma volume (as in pregnancy, other diseases) may cause anaemia even with a normal total circulating red cell and haemoglobin mass.The special problem is acute major blood loss, in wich anaemia is not immediately apparent because the total blood volume is reduced 1, 2 .
Classification of anaemia
There are a few different classifications of anaemia, but two most frequent used classifications are: those based on red cell indices (the mean corpuscular volume =MCV) and morphologic features and on pathophysiologic aspects.
Due to red cell indices (MCV) and morphologic features anaemia is divided into:
1. microcytic anaemia (MCV<80fl): iron deficiency, anaemia of chronic disorders, thalassemias, sideroblastic anaemia;
2. macrocytic anaemia (MCV>90/100fl): megaloblastic (vitamin B12 or folate deficiency) and non-megaloblastic anaemia (myelodysplastic syndroma, liver diseases, etc); 3. normocytic,normochromic anaemia (MCV 80-95fl): the most anaemias of chronic disorders, many haemolytic anaemias, after acute blood loss.
Due to pathophysiologic classification anaemia is divided into:
1. anaemia caused by decreased red cell production : at the level of haematopoietic stem cell (aplastic anaemia, pure red cell aplasia, anaemias due to bone marrow infiltration in haematologic and other solid metastatic malignancies), anaemias with disturbances of DNA synthesis (megaloblastic anaemias) or haemoglobin synthesis (haemoglobinopathias, thalassemias, iron deficiency); 2. anaemia caused by increased erythrocyte destruction : haemolytic anaemias (intrinsic abnormalities-membrane defect, enzyme deficiency and haemoglobin abnormalities; and extrinsic abnormalities -immune and non-immune); 3. anaemias caused by blood loss -acute and chronic. In order to define the anemia type the following laboratory analysis are needed: haemoglobin concentration, total red cell number, including morphologic features, MCV, reticulocyte number (normal 0,5-2,5%), iron stores (the best test is serum ferritin), signs for haemolysis (re-ticulocytosis, high serum total and unconjugated bilirubin ,high serum LDH, low serum haptoglobin, positive urin urobilinogen, positive direct Coombs'test). Also, it is very important to have the data about abnormalities of other peripheral blood cells( total number and differential count of white blood cells, number of platelets) because it may show the etiology of abnormalities and be helpful for further patient's preopertive prepartion 1, 3, 4, 5 .
Algorithm of analysis in anaemia
Concerning morphologic and pathophysiologic classification of anemias, and laboratory results particularly about iron stores and haemolysis of erythrocytes, we use the following steps in algorithm for rapid definition of anaemia type:
1. In microcytic anaemia it is obvious to analyse iron stores, by serum ferritin as the best test. Aanemia of iron deficiency is defined with very low serum ferritin (as well as with low serum iron and high total iron-binding capacity, TIBC). Normal or high iron stores are seen in other types of anaemia, such as anaemia of chronic disease, myelodysplatic syndromes, haemoglobinopathias, etc.
2. In macrocytic anaemia it is obvious to analyse the reticulocyte number. If it is normal, the bone marrow analysis should be done in order to define megaloblastic or non-megaloblastic anaemia. If the reticulocyte number is risen, the analysis for haemolysis of erythrocyte should be done. Reticulocytes usually rise in haemolytic anaemias, but also slightly in chronic blood loss, as well as during the reticulocyte crisis 7-9. day after the beginning of vitamin B12 and folate therapy in megaloblastic anaemias of their deficiency.
Anaemia of acute blood loss
Acute blood loss is very important problem during preoperative preparation of patients. After a single episode of blood loss, there is initial vasoconstriction with a reduction in total blood volume. After that, the plasma volume rapidly expands and the haemoglobin and packed red cell volume fall, and there is a rise in neutrophils and platelets. The reticulocyte response begins on the 2 nd or 3 rd day and lasts 8-10 days. The haemoglobin begins to rise by about the 7 th day, if iron stores are normal. There is no need for red cell and blood transfusions in blood loos less than 500ml, but it becomes necessary if the loss is continuing and more than 1000ml, concerning all risks especially possible viral transmission. Massive blood loss (about 50% of total blood volume or volume which is similar to total circulating blood volume during 24 hours) is the cause of not only the loss of erythrocytes but also platelets and coagulation factors. Red cells transfusions contribute to further decreasing of platelets and coagulation factors. So, in this situation, patients are treated with transfusions of platelets (to reach platelets over 50, 80-100x10 9 /l, especially in bleeding in polytrauma and cerebral haemorrhage), fresh frosen plasma 15ml/kg, .
Therapy of anaemia in preoperative preparation of patients
Therapy approach during preopertive preparation of patients with anaemia depends on type and degree of anaemia and urgency of surgery. If there is need for red cell transfusions, it should be kept on mind that every single red cell unit given to adult of average body mass increases haematocrit value for 0,03 (3%), haemoglobin concentration for 1g/dl, with the maximum of effects 24 hours after transfusion 2 . During perioperative period, the decission for transfusion is made according to the degree of blood loss,which is cause of hypovolemia and decrease of haemoglobin concentration at the same time. This kind of hypovolemia should be treated initially with cristaloid/coloid infusions. The most common treshhold for red cell transfusions is haemoglobin level of 10,0g/dl and hematocrit of 0,30 in all normovolemic anaemias,with possible significantly lower limits in haemodynamic stable patients. Also, in patient with significant cardiovascular comorbidities (such as coronary artery disease) transfusions should be given even with haemoglobin level more than 10g/l.
Packed (plasma-depleted) and resuspended red cells are the most common used component of blood for correction of anemia. Also, other haemoproducts susch as filtrated, washed, leucocyte-depleted and platelet-deplated red cells, or irradiated red cells might be used in some patients with anaemia in order to prevent biologic complications of transfusion (febrile nonhaemolytic reaction, acute lung injury, alloimmunisation, etc). These products are prepared using special filters for leucocytes, washing in saline fluids or treating by irradiation.These products are especcially useful (with corticosteroid premedication) in autoimmune haemolytic anaemias, or in patients ongoing transplantation programme, due to the HLA alloimmunisation problems.
Transfusion of neocytes (young erythrocytes with lower iron level, more 2,3 DPG and longer lifespan of 90 days comparing to conventional red cells used in transfusion with lifespan of 50-60 days ) should be given in rare anaemias such as thalassemias and aplastic anaemia, with often transfusions therapy. Neocytes are prepared from the whole blood unit using special technique.
Preoperative autotransfusion in order to colect autologous erythrocytes for further expected need for red cell transfusion is possible in all patients in good condition, with haemoglobin of 11g/dl, hematocrit over 0,34 and surgery planned within 2 to 5 weeks. 2 The specific anaemia treatment should be given immediately together with haematologist consultation, in all anaemias with iron, vitamin B12 and folate deficiency, acquired haemolytic anaemias and surgery planned within a month.Therapy is given according to the anaemia degree and initial haemoglobin concentration. In iron deficiency anaemia preparation of iron 100-200 mg daily are given up to one month after normalisation of haemoglobin level, to restore iron stores. In megaloblastic anemia with vitamin B12 deficiency vitamin B12 is given 6x1000µg im 3-4 weeks, and after that every 3 months for life; in anaemia with folate deficiency folic acid 5 mg oral daily for 4 months is given. Acquired haemolytic anaemias are treated with corticosteroids 1-2 mg/kg body mass daily.
In anaemia of chronic renal failure, usually during dialysis, recombinant erythropoietin is given (3 times weekly, or once every 2 weeks, if glycosylated longer acting form is used). Also, the therapy of chronic disease is continuing 3,4,5 .
ERYTHROCYTOSIS Definition of erythrocytosis
The term erythrocytosis applies to patients who have increase of haemoglobin concentration due to normal values for gender and age. Also, it means limit levels for hematocrit over 0,51 for adult males and over 0,48 for women .
Classification of erythrocytosis
Due to pathophysiological classifiaction erythrocytosis is divided into 2 big groups-absolute (primary and secondary) and relative erythrocytosis:
1. absolute erythrocytosis -with increased total red cell volume(>35 ml/kg in men and >32ml/kg in women ) and normal total plasma volume (40-50 ml/kg) 2. relative erythrocytosis -with normal total red cell volume, but decreased total plasma volume.
Relative erythrocytosis are seen in patients with stress, cigarette smoking, in dehidration with plasma loss (vomiting, enteropathy, burns).
Absolute erythrocytosis is divided into primary and secondary. Secondary erythrocytosis are caused by compensatory erythropoietin increase in hypoxaemia (high altitudes, pulmonary disease, congenital cardiovascular disease with cyanosis), by inappropriate erythropoietin increase in renal diseases (hydronephrosis, cysts, stenosis a.renalis) or by erythropoietin-like cytokines in various tumours (uterine leiomyoma, hepatocellular carcinoma, cerebellar, adrenal and kidney tumours). Also, secondary erythrocytosis might be congenital in patients with abnormal haemoglobins such as haemoglobins with high affinity for O2 and methaemoglobinopathia, and familial increase erythropoietin production. Primary erythrocytosis might be congenital (abnormalities of erythropoietin receptors in familial polycythemia) and acquired (polycythemia vera) in malignant myeloproliferative stem cell disorder 6, 7 .
Algorithm of analysis in erythrocytosis
Concerning basic characteristics and pathophysiologic classification of erythrocytosis, including anamnesis, clinical signs and laboratory results, the differential diagnosis between absolute and relative, and primary and secondary erythrocytosis should be done. It is obligatory to do following laboratory analysis (including peripheral blood counts analysis): arterial oxygen saturation, serum vitamin Br. 2 Preoperative preparation of the patient with the 79 abnormalities of red and white blood cells B12, serum erythropoietin, total red cell volume and total plasma volume, neutrophil alkaline phosphatase score (NAP, staining on peripheral blood smears ). If it is polycythemia vera (increased total red cell volume with normal total plasma volume, arterial oxygen saturation >95%, elevated NAP and serum B12, low serum erythropoietin) further haematologic investigations are needed 6, 7 .
Therapy of erythrocytosis during preoperative preparation of patients
Clinical features of all erythrocytosis depends of the erythrocytosis degree, which causes blood hyperviscosity (headache, dispnea, visual disturbances, dizziness). So, the treatment is aimed at decreasing of circulating red cells and maintaining a normal hematocrit, using venesection (phlebotomy) usually 300-400ml (several time in one week). In patients with secondary erythrocytosis and clinical features of hyperviscosity venesections should be done if hematocrit is >0,56, but >0,52 in patients who are cigarette smoking and have arterial hypertension, ischemic cardiovascular disease, transient ischemic attacks or previous thrombotic events. Those patients should have hematocrit level of 0,45-0,47. The optimal level of hematocrit in polycythaemia vera is 0,45, considering that those patients might have increasing number of platelets. If platelets are over 400x10 9 /l, patients should be treated, (after consultation with haematologist)with myelosuppressive drug hydroxiurea and aspirin to prevent thrombotic events. However, these patients have also abnormalities of platelets' function and therefore increased risk for haemorrhage as well. So, during preoperative preparation of patients, rithm of venesections depends on degree and type of erythrocytosis, type of planned surgery, expected perioperative bleeding, with adding anticoagulant therapy in patients with thrombocytosis.
2,6,7

WHITE BLOOD CELLS DISORDERS
The white blood cells (leucocytes) may be devided into 2 big groups: the phagocytes (polymorph neutrophils, eosnophils and basophils granulocytes, and monocytes) and immunocytes (lymphocytes and their precursors, and plasmocytes). In peripheral blood of haelthy person there are only mature phagocytes and lymphocytes. The function of these cells is in protecting the body against infection closely connected with two soluble protein systems, immunoglobulins and complement.
The granulocyte and monocyte series arises in bone marrow from the progenitor haematopietic stem cell in the process of differentation and proliferation controled by many growth factors, such as interleukins (IL-1, IL-3, IL-5, IL-6, IL-11), macrophage, granulocyte and monocyte stimulating factors (GM-CSF, G-CSF, M-CSF). These growth factors also affect the function of mature cells: phagocytosis, superoxide generation and cytotoxicity in the case of neutrophils; phagocytosis, cytotoxicity and production of other cytokines by monocytes. In the normal state, the bone marrow storage compartment contains 10-15 times the number of granulocytes found in the peripheral blood. Following their release from the bone marrow, granulocytes spend only 6-10 hours in the circulation, before moving into the tissues where they perform their phagocytic function, spending average 4-5 days before destruction.Monocytes spend more shorter in bone marrow than granulocytes, after circulating for 20-40 hours leave the blood and enter the tissues,where they mature and carry out their principal functions. After their transformation to macrophages they may have lifespan as long as several months, or even years.
Lymphocytes are the immunologically competent cells that assist the phagocytes in defence of the body against infection. In postnatal life, the bone marrow and thymus are the primary lymphoid organs in which lymphocytes develop. The secondary lymphoid organs in which specific immune responses are generated are the lymph nodes, spleen and lymphoid tissues of the alimentary and respiratory tracts. The immune response depends upon complex intereactions between B and T lymphocytes, NK cells (cytotoxic CD8+ cells without T-cell receptor), plasmocytes (mature B cells producing immunoglobulins), antigenpresenting cells, complement and number of cytokines.
Normal leucocyte blood counts are 4-11x10 9 /l (with neutrophils 2,5-7,5; eosinophils 0,04-0,4; basophils 0,01-0,1; monocytes 0,2-0,8; lymphocytes 1,5-3,5) for adults of white race. Disorders of leucocyte function are congenital (rare) and acquired, which are accompanied with leucocyte number abnormalities, the both leucocytosis and leucopenia 2, 8, 9 .
2.1.LEUCOCYTOSIS
An increase in total leucocyte number, as well as increse in every single group of phagocytes or immunocytes, might be observed in many disorders such as primary haematologic diseases (acute and chronic lymphoproliferative and myeloproliferative neoplasms, mostly in leukaemias, lymphomas, myelomas etc.), but also during acute and chronic infections, inflammation and tissue necrosis, metabolic disorders, neoplasms of all non-haematologic types, acute haemorrhage and haemolysis, using some drugs, allergic and autoimmune diseases, etc. Occasionally, there is excessive leucocytosis (>50x10 9 /l) characterized by the presence of immature cells (e.g. myeloblasts, promyelocytes and myelocytes, or activated lymphoid cells and lymphocytes). These leukaemoid reactions are associated with severe systemic infections, haemolysis or metastatic cancers. So, in all leucocytosis it is very important to analyse the leucocyte differential formula (in blood analyser and on blood smears), the absolute numbers of all cells, and after that if there are abnormalities in other peripheral blood cells or clinical signs, to consult haematologist for further diagnostic approach 8, 9 .
LEUCOPENIA
Neutropenia is the most common observed leucopenia with clinical significance for preoperative preparation of patients. Neutropenia may be a part of a general pancytopenia (bone marrow failure in haematologic malignan-80 D. Tomin ACI Vol. LVIII cies or metastatic solid tumours, in aplastic anaemia), or selective, which is usually acquired after large numbers of drugs (anti-inflammatory, antibacterial, anticonvulsants, antithyroids, phenothiasines, psychotropics and antidepressants etc.), in autoimmune systemic disorders, infections (particularly viral, but also fulminant bacterial, e.g. miliary tuberculosis and typhoid ). Agranulocytosis is the most severe neutropenia (<0,5 x10 9 /l).These patients with agranulocytosis are very susceptible to infections. This susceptibilty for infection is associated also with lower neutropenia (0,5-1,0 as well as 1,0-1,5x10 9 /l), lasting more than 7 days, in patients in intensive care units, with central venous or urinary catheters, treated with steroids or other immunosuppressive drugs. Those patients are at great risk not only of bacterial but also invasive fungal infections (particularly candida and aspergillus).
Lymphopenia may occur in all severe bone marrow failure, in haematologic disorders after therapy with myeloablative drugs and steroids, radiotherapy, in inherited or acquired immunodeficiency. Acquired immunodeficiency are predominantly B cell (antibody deficiency seen in multiple myeloma, nephrotic syndrome, protein-loosing enteropathy), predominantly T cell (AIDS, lymphomas, after therapy with steroids, immunosuppressive drugs, fludarabine) and combined B and T cell (chronic lymphocytic leukaemia, post-bone marrow transplantation, post-chemotherapy and radiotherapy).
In sepsis, particularly in septic shock, at the onset, leucocyte number may initially decrease to < 4,0x10 9 /l, with polymorphonuclears lower than 20%. However, this situation reverse within 1-4 hours, and a significant increase in both the total leucocyte number over 15x10 9 /l and polymorphonuclears over 80% usually occurs. Also, decrease in platelet count to <50x10 9 /l is often present 2, 8, 9, 10, 11, 12 .
Preoperative preparation of patients with abnormal leucocyte count
Haematology diagnostic procedures should be done in every patient with suspected haematologic disorder. Leucocytosis in chronic lymphoproliferative and myeloproliferative diseases may be under control with 1-2 month of adequate haematologic therapy. So, it should be given in preoperative preparation of patients and not urgent surgery. The largest problem in patients with leucocytosis are neutropenia and acquired immunodeficiency, which are associated with postoperative comlications.
So, concerning rules of asepsis and antisepsis, those patients need prophylaxis of infections, including oral antibacterial (co-trimoxasole, ciprofloxacin, colistin) and antifungal drugs (fluconasole, itraconasole, posaconasole). The granulocyte stimulating factor G-CSF is used as a neutrophil producing stimulating factor in patients after chemotherapy or in autoimmune drug-induced agranulocytosis. Concerning algorithms in patients with febrile neutropenia, after microbiology analysis, broad spectrum antibiotics should be given immediately (meropenem, tazocin, vancomycin/teicoplanin), with parentheral antifungal therapy in patients with probably and proven fungal infections.
Granulocyte concentartes have been used rarely, due to often posttransfusional reactions, e.g. HLA sensibilisation. But, in some patients with agranulocytosis not responding to given antibiotic and antifungal therapy, granulocyte concentrates might be given with premedication (antihistaminics, analgo-antipyretics and corticosteroids). Literature data are confirming significant efficiency of granulocyte concentrates in therapy of sepsis in neonatal period, rare in adults with invasive fungal infections, and after various transplantations. Also, during preoperative preparation of patients with immunodeficiency and hypogammaglobulinemia, intravenous immunoglobulins (IVIG) are used up to 0,4mg/Kg daily. IVIG have protective functions increasing the activity of antimicrobic effector systems such as opsonins-mediated phagocytosis and antibody and complement dependent cell-mediated cytotoxicity. According to the literature data, there is also an immunomodulatory effect of IVIG to circulating immunoglobulins, B cells etc. After IVIG application it's lifespan is 3 weeks at least 2, 8, 9, 10, 11 .
CONCLUSION
The complete peripheral blood count analysis including laboratory screening tests of haemostasis and coagulation schould be done in every patient before surgery. If there are abnormalities in red and white blood cell counts, indicating possible haematologic disorder, haematologist should be included in further diagnostic procedures and therapy. Patients with anaemia and no urgent surgery are treated according to the anaemia cause with iron, vitamin B12, folic acid, steroids or recombinant erythropoietin. Transfusion of red cells are given to the patients with severe anaemia and urgent surgery. Phlebotomy is used in patients with erythrocytosis in order to decrease the circulating red cell mass, but concerning the expected perioperative bleeding. Neutropenia and immunodeficiency are the most important abnormalities in patients with white blood cell disorders. So, those patients need prophylaxis of infections, therapy of febrile neutropenia with broad spectrum antibiotics and antifungal drugs, rarely recombinant granulocyte factor, transfusion of granulocyte concentrates and intravenous immunoglobulins.
SUMMARY
PREOPERATIVNA PRIPREMA BOLESNIKA SA POREME]AJEM BROJA ERITROCITA I LEUKOCITA U bolesnika koji su predvidjeni za bilo koju hiruršku intervenciju neophodno je, u okviru preoperativnih nalaza, uraditi kompletnu krvnu sliku uz rutinske testove hemostaze i koagulacije, kako bi se, ako postoje, uo~ili poreme}aji koji ukazuju na primarnu hematološku bolest ili hematološki poreme}aji u okviru nekih drugih bolesti. Ovi poreme}aji bi mogli da budu uzrok zna~ajnih komplikacija tokom i posle operativnog zahvata. Anemije su naješ}i hematološki poreme}aj koji se vidja u toku preoperativne pripreme bolesnika. Terapijski pristup zavisi od Br. 2 Preoperative preparation of the patient with the 81 abnormalities of red and white blood cells tipa i stepena anemije, vrste hirurške intervencije, te vremena kada ona treba da se uradi. U svim oblicima anemija usled nedostatka gvo'dja, megaloblastnim anemijama, ste~enim hemoliznim i anemiji u hroni~noj bubre'noj insuficijenciji (ukoliko hirurški zahvat nije neophodan unutar narednih mesec dana, u zavisnosti od stepena anemije) treba po~eti specifi~nu terapiju anemije (preparati gvo-'dja, vitamin B12, folati, kortikosteroidi, rekombinantni eritropoetin). Pri tome, naj~eš}i "prag" za transfuziju eritrocita je nivo hemoglobina od 10,0g/dl i hematokrit od 0,30, kada je re~ o euvolemijskoj anemiji, a kod hemodinamski stabilnih bolesnika ovaj prag mo'e biti i znatno ni'i. U bolesnika koji imaju eritrocitozu terapija je usmerena ka smanjenju broja cirkulišu}ih eritrocita, što se posti'e flebotomijama, vode}i ra~una o o~ekivanom perioperativnom krvarenju. Kod bolesnika sa poreme}ajem broja leukocita i sumnjom na primarnu hematološku bolest treba odmah uklju~iti hematologa u dijagnosti~ku proceduru definisanja poreme}aja. U bolesnika sa leukocitozom u leukemijama ve}i je problem stvarni stepen neutropenije koji ovi bolesnici imaju nego stepen leukocitoze. Stoga je u okviru terapije ovakvih bolesnika obavezna prevencija infekcija, primena granulocitnog hematopoetskog faktora rasta, a u slu~aju febrilne neutropenije, primena antibiotika širokog spektra i obavezno anti-gljivi~ne terapije, redje transfuzija granulocitnih koncentrata i imunoglobulina za intravensku primenu.
Klju~ne re~i: preoperativna priprema, anemija, eritrocitoza, leukocitoza, leukopenija
